Advertisements

Johnson & Johnson to submit applications for at least 10 new drugs by 2023

Johnson & Johnson to submit applications for at least 10 new drugs by 2023.....»»

Category: global-financeSource: reutersMay 15th, 2019

Oklahoma makes final bid to hold J&J responsible for opioid epidemic

Oklahoma makes final bid to hold J&J responsible for opioid epidemic.....»»

Category: global-financeSource: reutersJul 31st, 2019

Oklahoma makes final bid to hold Johnson & Johnson responsible for opioid epidemic

Oklahoma makes final bid to hold Johnson & Johnson responsible for opioid epidemic.....»»

Category: global-financeSource: reutersJul 31st, 2019

J&J warns of hit from generic drugs in third quarter, shares fall

J&J warns of hit from generic drugs in third quarter, shares fall.....»»

Category: global-financeSource: reutersJul 16th, 2019

Johnson & Johnson beats profit estimates on pharma strength, raises sales outlook

Johnson & Johnson beats profit estimates on pharma strength, raises sales outlook.....»»

Category: global-financeSource: reutersJul 16th, 2019

J&J profit boosted by better-than-expected pharma unit sales

J&J profit boosted by better-than-expected pharma unit sales.....»»

Category: global-financeSource: reutersApr 16th, 2019

Johnson & Johnson reports first-quarter sales above expectations

Johnson & Johnson reports first-quarter sales above expectations.....»»

Category: global-financeSource: reutersApr 16th, 2019

J&J beats estimates on pharma strength, raises sales forecast

J&J beats estimates on pharma strength, raises sales forecast.....»»

Category: global-financeSource: reutersApr 16th, 2019

J&J baby shampoo samples fail Indian quality test; company rejects findings

J&J baby shampoo samples fail Indian quality test; company rejects findings.....»»

Category: global-financeSource: reutersApr 1st, 2019

India drugs regulator finds no asbestos in J&J talc: sources

India drugs regulator finds no asbestos in J&J talc: sources.....»»

Category: global-financeSource: reutersFeb 28th, 2019

J&J becomes first drugmaker to add prices to television ads

J&J becomes first drugmaker to add prices to television ads.....»»

Category: global-financeSource: reutersFeb 7th, 2019

Johnson & Johnson raises U.S. prices on around two dozen drugs

Johnson & Johnson raises U.S. prices on around two dozen drugs.....»»

Category: global-financeSource: reutersJan 10th, 2019

Regulator orders J&J to stop using raw material to make Baby Powder in India

Regulator orders J&J to stop using raw material to make Baby Powder in India.....»»

Category: global-financeSource: reutersDec 21st, 2018

Indian regulator orders J&J to stop using raw material to make Baby Powder in India - source

Indian regulator orders J&J to stop using raw material to make Baby Powder in India - source.....»»

Category: global-financeSource: reutersDec 20th, 2018

Indian drugs regulator orders J&J to stop using raw material to make Baby Powder in India: source

Indian drugs regulator orders J&J to stop using raw material to make Baby Powder in India: source.....»»

Category: global-financeSource: reutersDec 20th, 2018

J&J beats profit estimates, lifts outlook on pharma unit strength

J&J beats profit estimates, lifts outlook on pharma unit strength.....»»

Category: global-financeSource: reutersOct 16th, 2018

Johnson & Johnson profit beats, lifts forecast on cancer drug demand

Johnson & Johnson profit beats, lifts forecast on cancer drug demand.....»»

Category: global-financeSource: reutersOct 16th, 2018

Johnson & Johnson quarterly profit rises 4.5 percent

Johnson & Johnson quarterly profit rises 4.5 percent.....»»

Category: global-financeSource: reutersOct 16th, 2018

Johnson & Johnson profit beat fueled by strength in pharma business

Johnson & Johnson profit beat fueled by strength in pharma business.....»»

Category: global-financeSource: reutersJul 17th, 2018

After split from Actelion, Idorsia CEO plans to raise more cash in 2019

After split from Actelion, Idorsia CEO plans to raise more cash in 2019.....»»

Category: global-financeSource: reutersJun 18th, 2018

J&J quarterly profit beats on demand for cancer drugs

J&J quarterly profit beats on demand for cancer drugs.....»»

Category: global-financeSource: reutersApr 17th, 2018